Furthermore, Siglec6-targeting T cell-recruiting biAb (T-biAb), which has been developed for chronic lymphocytic leukemia (CLL) [81], efficiently eliminates Siglec-6+ leukemia and B cells and preserves Siglec-6− healthy B cells. Here, SIGLEC6 is linked to B-cell chronic lymphocytic leukemia.